GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accelerated Pharma Inc (NAS:ACCP) » Definitions » PB Ratio

Accelerated Pharma (Accelerated Pharma) PB Ratio : (As of Apr. 29, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Accelerated Pharma PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-29), Accelerated Pharma's share price is $0.00. Accelerated Pharma's Book Value per Share for the quarter that ended in Mar. 2017 was $-1.02. Hence, Accelerated Pharma's PB Ratio of today is .

The historical rank and industry rank for Accelerated Pharma's PB Ratio or its related term are showing as below:

ACCP's PB Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.94
* Ranked among companies with meaningful PB Ratio only.

Back to Basics: PB Ratio


Accelerated Pharma PB Ratio Historical Data

The historical data trend for Accelerated Pharma's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerated Pharma PB Ratio Chart

Accelerated Pharma Annual Data
Trend Dec14 Dec15 Dec16
PB Ratio
- - -

Accelerated Pharma Quarterly Data
Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
PB Ratio Get a 7-Day Free Trial - - - - -

Competitive Comparison of Accelerated Pharma's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Accelerated Pharma's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Accelerated Pharma's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Accelerated Pharma's PB Ratio distribution charts can be found below:

* The bar in red indicates where Accelerated Pharma's PB Ratio falls into.



Accelerated Pharma PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Accelerated Pharma's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2017)
=0.00/-1.015
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Accelerated Pharma  (NAS:ACCP) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Accelerated Pharma PB Ratio Related Terms

Thank you for viewing the detailed overview of Accelerated Pharma's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Accelerated Pharma (Accelerated Pharma) Business Description

Traded in Other Exchanges
N/A
Address
Website
Accelerated Pharma Inc, is a Delaware corporation organized on May 12, 2014. It is a biopharmaceutical company focused on utilizing its genomic technology to enhance the development and commercialization of pharmaceutical products. Its lead product candidate is Picoplatin, a new generation platinum-based cancer therapy that has the potential for use in different formulations, as a single agent or in combination with other anti-cancer agents, to treat multiple cancer indications.

Accelerated Pharma (Accelerated Pharma) Headlines

No Headlines